Alan J. Tuchman - Jun 30, 2025 Form 4 Insider Report for TAO Synergies Inc. (TAOX)

Role: Chief Medical Officer, Director
Signature: /s/ Robert Weinstein, Attorney-in-fact
Stock symbol: TAOX
Transactions as of: Jun 30, 2025
Transactions value $: -$13,549
Form type: 4
Date filed: 7/2/2025, 04:05 PM
Previous filing: Dec 20, 2022
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
TUCHMAN ALAN J	Chief Medical Officer, Director	C/O TAO SYNERGIES INC., 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK	/s/ Robert Weinstein, Attorney-in-fact	2025-07-02	0001417631

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TAOX	Common Stock, par value $0.0001 per share	Award	$0	+4.32K	+326.89%	$0.00	5.64K	Jun 30, 2025	Direct	F1
transaction	TAOX	Common Stock, par value $0.0001 per share	Tax liability	-$13.5K	-1.73K	-30.63%	$7.85	3.91K	Jun 30, 2025	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes (i) 4,315 restricted stock units granted on June 30, 2025, under the Issuer's 2020 Equity Incentive Plan which vested immediately upon issuance and (ii) 1,320 shares of common stock.
F2	Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction.